Skip to main content
. Author manuscript; available in PMC: 2015 Dec 1.
Published in final edited form as: Prostate Cancer Prostatic Dis. 2015 Feb 10;18(2):144–148. doi: 10.1038/pcan.2015.2

Table I. Patient Characteristics.

Characteristic Total (n = 30)
Median age, range (years) 72, 55 – 86
Zubrod Performance Status
 0 16
 1 13
 2 1
Median pre-treatment PSA, range (ng/ml) 73, 7 – 11,420
Median hemoglobin, range (g/dL) 12.8, 9.7 – 15.5
Median alkaline phosphatase, range (U/L) 96, 36 – 271
Median creatinine, range (mg/dL) 0.87, 0.60 – 1.83
Prior therapy (# patients)
 LHRH antagonist 30
 AR antagonist 30
 Docetaxel 30
 Cabazitaxel 1
 Vinorelbine 1
 Abiraterone 4
 Orteronel 2
 Enzalutamide 1
 Sipuleucel-T 4
 Atrasentan 1
 Silutuximab 1
 Cabozantanib 1